+CURA
+CURA is not just a technological advancement; it’s a beacon of hope for patients and a tool for practitioners, promising a future where diagnostics are no longer a bottleneck but a catalyst for healing. Through this collaboration, +CURA is poised to redefine the boundaries of healthcare, making rapid diagnostics a reality for everyone, everywhere.
+CURA is a purposefully built universal LIMS enabling self-requested testing from any health or care setting to any reporting system. Leveraging inicio’s extensive integration expertise, +CURA integrates effortlessly with EHRs and national architecture, delivering a smooth and efficient experience for patients and clinicians alike.
At the heart of +CURA lies a shared vision: to democratise access to rapid diagnostics across diverse locations, making it easier, faster, and more efficient for healthcare providers to deliver exceptional care. Newfoundland Diagnostics brings to the table its mission-driven approach to make healthcare products affordable and accessible worldwide, offering a suite of at-home tests that pinpoint various conditions, deficiencies, and diseases early.
This complements inicio health’s dedication to a clinically-led, patient-centric ethos, where cutting-edge solutions are crafted through a design-led, agile methodology, leveraging AI, automation, data analytics, and strategic insights to enhance healthcare delivery.
How does this affect the NHS and its patients?
Increasing need to deliver more care outside of hospital walls, rise in adoption of virtual ward provision for admission avoidance and early discharge, a need to understand population health in real time across national screening programmes, a need to do more to answer causation factors to our health inequalities – outreach to our seldom heard citizens.
+CURA can deliver at home tests designed to detect early stage disease across a number of pathways. Able to outreach into the seldom heard communities, optimise capability for virtual ward delivery, support national screening programmes with real time status data. Avoiding the need for patients to travel into care settings for tests that could be performed in home settings.
There is an overwhelming amount of evidence supporting self and at home testing not least from a patient enablement point of view but in terms of shifting us form a medical delivery model to a social one – Prevention really is better than cure for patients and healthcare budgets